Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Eivin Dahl"'
Autor:
Einar Furulund, Tesfaye Madebo, Karl Trygve Druckrey-Fiskaaen, Jørn Henrik Vold, Mette Hegland Nordbotn, Eivin Dahl, Sindre M. Dyrstad, Torgeir Gilje Lid, Lars T. Fadnes, for the ATLAS4LAR study group
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-9 (2024)
Abstract Background Substance use disorder is associated with unhealthy lifestyle choices, resulting in adverse social and health consequences. People with opioid use disorder receiving opioid agonist therapy, in particular, have high morbidity and r
Externí odkaz:
https://doaj.org/article/3475dda19bc8430481cf24061b573411
Autor:
Karl Trygve Druckrey-Fiskaaen, Einar Furulund, Tesfaye Madebo, Siv-Elin Leirvåg Carlsen, Lars T. Fadnes, Torgeir Gilje Lid, for ATLAS4LAR Study Group, Vibeke Bråthen Buljovcic, Jan Tore Daltveit, Trude Fondenes, Per Gundersen, Beate Haga Trettenes, Mette Hegland Nordbotn, Maria Olsvold, Marianne Cook Pierron, Christine Sundal, Jørn Henrik Vold, Maren Borsheim Bergsaker, Eivin Dahl, Tone Lise Eielsen, Torhild Fiskå, Marianne Larssen, Eirik Holder, Ewa Joanna Wilk, Mari Thoresen Soot
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2023)
IntroductionSmoking-related diseases are major contributors to disability and shorter life expectancy among opioid-dependent patients. Smoking prevalence is considerably higher for opioid-dependent persons than among the general population, and only
Externí odkaz:
https://doaj.org/article/1eb790fdbc254820965bb5e36bf45734
Autor:
Håvard Midgard, Ronny Bjørnestad, Maren Egeland, Eivin Dahl, Ane‐Kristine Finbråten, Knut B. Kielland, Martin Blindheim, Olav Dalgard
Publikováno v:
Liver international
Background & aims: New models of HCV care are needed to reach people who inject drugs (PWID). The primary aim was to evaluate HCV treatment uptake among HCV RNA positive individuals identified by point-of-care (POC) testing and liver disease assessme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e65bb62b13bf64a4b3316bc57d024939
https://doi.org/10.1111/liv.15266
https://doi.org/10.1111/liv.15266
Autor:
Einar Furulund, Tesfaye Madebo, Karl Trygve Druckrey-Fiskaaen, Jørn Henrik Vold, Mette Hegland Nordbotn, Eivin Dahl, Sindre Mikael Dyrstad, Torgeir Gilje Lid, Lars Thore Fadnes
Background Substance use disorder is associated with unhealthy lifestyle choices, resulting in adverse social and health consequences. People with opioid use disorder receiving opioid agonist therapy, in particular, have high morbidity and reduced qu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::818aa37f3e8d7ff9a799da6d7dbdaafa
https://doi.org/10.21203/rs.3.rs-1693049/v1
https://doi.org/10.21203/rs.3.rs-1693049/v1
